Laser Phase Plate Microscopy Pushes Cryo-EM Into Smaller Protein Territory
A new laser phase plate built at the University of California, Berkeley is designed to solve one of structural biology’s most stubborn problems: the inability of standard cryoelectron microscopy to clearly image many of the body’s smallest proteins. The device uses an exceptionally intense, tightly focused laser to alter the phase of an electron beam, increasing contrast without sacrificing the beam’s usefulness for imaging. In practical terms, that means structures that once blended into background noise may now stand out well enough to reconstruct in much sharper detail.
The immediate significance lies in scale. Conventional cryo-EM has transformed protein science over the past decade, but proteins below roughly 70 kilodaltons remain difficult to resolve, and many of the body’s most biologically important molecules fall below that range. The new system has already improved imaging of proteins down to about 50 kilodaltons, and the researchers believe the approach could ultimately reach even smaller targets. If that happens, the method will extend structural biology into territory that has stayed stubbornly out of reach.
Why Contrast Has Been the Bottleneck
Biological tissue is mostly water, so cells are naturally transparent under ordinary light microscopy. Electron microscopy offers the magnification needed to study proteins and molecular assemblies, but small specimens still generate weak signal relative to surrounding background. The problem is not magnification alone. It is contrast.
Phase contrast changed light microscopy almost a century ago by converting tiny phase shifts in transmitted light into visible differences in brightness. The Berkeley group has now applied the same principle to electron beams. Rather than adding stains, which can destroy cells, the new approach preserves frozen biological material while making subtle structural differences easier to see. For cryo-EM, that change is not cosmetic. It directly affects whether a particle can be identified, aligned, and reconstructed at all.
One sentence captures the technical stakes: without stronger contrast, many proteins simply remain too small to analyze reliably.
How the Laser Changes the Electron Beam
The engineering challenge was formidable. The team developed what it describes as the world’s most intense focused continuous-wave laser and confined it within a spherical mirror chamber, where the light reflects more than 10,000 times. That design concentrates energy into a tiny focal point and creates enough phase shift to influence the electron beam passing through the microscope.
Holger Müller, who led the development effort, described the setup as 75 kilowatts focused to a few microns, a power density more intense than welding and greater than a military laser. The description sounds almost theatrical, but the reason is straightforward physics: the laser must be intense enough to change the electron beam by 90 degrees in phase, which is the threshold needed for the imaging improvement the team sought.
The modified instrument, named Theia, was built on a state-of-the-art Thermo Fisher Krios cryo-EM platform. A related two-laser system is under construction at Biohub’s imaging facility in Redwood City, where two beams positioned at right angles each operate at about half power to reduce burnout and optical distortion. Both projects are being developed with Thermo Fisher Scientific.
What the First Images Showed
The Berkeley group tested the upgraded microscope on six samples that varied in size and preparation quality. Across those tests, the laser improved image resolution, with the largest gains appearing in specimens that are normally hardest to image. That matters because the best-case specimen can already look good on standard cryo-EM. The real clinical and biological value comes when the sample is small, fragile, or less than ideal.
The researchers used two proteins to demonstrate the system’s performance: aldolase and hemoglobin. Aldolase is relatively easy for modern cryo-EM systems to image, while hemoglobin sits much closer to the lower size boundary that has challenged conventional instruments. The laser phase plate improved both structures, but the gain was especially marked for hemoglobin. In other words, the instrument does not merely sharpen what is already easy; it extends the usable range of the technology toward proteins that have been nearly invisible.
Why Cryo-ET Could Benefit Even More
The broader promise may lie in cryoelectron tomography, or cryo-ET. Unlike single-particle cryo-EM, which studies isolated molecules, cryo-ET reconstructs three-dimensional views from multiple angles and can show proteins in their native cellular surroundings. That offers a far more realistic picture of how molecular machines interact inside cells. It also makes the contrast problem harder, because the microscope must distinguish one small structure from a dense, crowded cellular background.
Bridget Carragher described the challenge as trying to find one leaf on one tree in a forest. That image fits the biology well. Inside a cell, proteins are not floating in empty space. They sit among membranes, organelles, and countless neighboring molecules, all of which compete for visual attention. A higher signal-to-noise ratio could turn cryo-ET from a promising tool into one capable of routine discovery.
The Protein Size Barrier Has Been a Major Knowledge Gap
Traditional cryo-EM has struggled with proteins smaller than about 70 kilodaltons, and proteins below that threshold make up about 90% of the human proteome. The new laser phase plate has already pushed imaging capability to about 50 kilodaltons, though that remains technically difficult. Müller believes the method could eventually reach proteins as small as 17 kilodaltons, the approximate size of myoglobin, if the system can be paired with a tightly focused electron beam.
If that next step works, the implication is substantial. A much larger share of human proteins could become structurally accessible without crystallization, and many molecular interactions now inferred indirectly could be visualized in their native setting. Drug discovery would also benefit, because many therapeutic targets remain structurally elusive precisely because they are too small for existing cryo-EM methods to image well.
This is not a modest optimization of an established workflow. It is an attempt to move the imaging floor downward far enough to expose a major portion of human biology that has remained out of reach.
What Still Has to Be Proven
The work now sits at an important technical threshold, but the next phase will determine whether the instrument performs consistently across broader biological samples and more routine experimental conditions. The current results show improved contrast and resolution in carefully tested specimens, yet the hardest targets remain the smallest proteins and the most crowded cellular environments. Reaching the predicted 17-kilodalton range will require further engineering, and the focused-electron-beam strategy has not yet been established in routine use.
The paper also sits at the intersection of hardware innovation and biological application. The microscope can reveal more, but its value will depend on whether researchers can translate sharper images into a clearer understanding of protein function, cellular organization, and disease mechanisms. For now, the key advance is technical and concrete: a laser-based phase plate has pushed cryo-EM closer to the molecular machinery that has long stayed hidden inside human cells.